Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yichang Three Gorges Pharmaceutical, a subsidiary of Humanwell Healthcare, is a leading Chinese pharmaceutical manufacturer specializing in antibiotics and amino acids. The company is globally recognized as the largest production base for Neomycin Sulfate, an aminoglycoside antibiotic used in human and veterinary medicine. Its extensive product portfolio includes various active pharmaceutical ingredients (APIs) such as Gentamicin Sulfate and essential amino acids like L-Isoleucine and L-Valine. Operating out of Yichang, Hubei, the company maintains high-standard GMP-certified facilities to support its large-scale fermentation and chemical synthesis processes. Yichang Three Gorges Pharmaceutical plays a critical role in the global supply chain for both finished dosages and bulk pharmaceutical chemicals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yichang Three Gorges Pharmaceutical.